Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 5Terminated 3Withdrawn 1Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Colorectal Neoplasms 42Stomach Neoplasms 16Pancreatic Neoplasms 16Rectal Neoplasms 10Neoplasms 10Neoplasm Metastasis 10Colonic Neoplasms 7Adenocarcinoma 7Carcinoma, Non-Small-Cell Lung 6Carcinoma, Hepatocellular 6Biliary Tract Neoplasms 5Gastrointestinal Neoplasms 4Esophageal Neoplasms 4Cholangiocarcinoma 4Burkitt Lymphoma 4Advanced Solid Tumors 4Adenocarcinoma Of Esophagus 4Leukemia, Biphenotypic, Acute 3Esophageal Squamous Cell Carcinoma 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Peritoneal Neoplasms 2Ovarian Neoplasms 2Locally Recurrent Rectal Cancer 2Gallbladder Neoplasms 2Endometrial Neoplasms 2Appendiceal Neoplasms 2Uterine Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Solid Tumors 1

Interventions

Doxorubicin 15pembrolizumab 12Cyclophosphamide 9Surgical Procedures, Operative 8Gemcitabine 8Blood Specimen Collection 8Ifosfamide 7Surveys and Questionnaires 6Nivolumab 6Trabectedin 5Radiotherapy 5Magnetic Resonance Spectroscopy 5Drug Therapy 5fludarabine 4Temozolomide 4Specimen Handling 4Radiation Dose Hypofractionation 4Biopsy 4selinexor 3pazopanib 3liposomal doxorubicin 3cabozantinib 3atezolizumab 3anlotinib 3Radiation 3Observation 3Docetaxel 3Dacarbazine 3trastuzumab deruxtecan 2toripalimab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Sarcoma × Leucovorin × Clear all
NCT03715933 2026-05-22

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

Inhibrx Biosciences, Inc

Phase 1 Recruiting
411 enrolled
Sarcoma

Sarcoma, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡